Are shareholders happy with Chemed Corp (USA Stocks:CHE) technical indicators?

All Stories . Fundamentals . 
Ellen Johnson .  Story
CHE Stock  USD 528.99  2.60  0.49%   
Ellen Johnson
By Ellen Johnson
Macroaxis Story
Chemed Corp Enterprise Value is projected to increase significantly based on the last few years of reporting. The past year's Enterprise Value was at 9.49 Billion. The current year Invested Capital is expected to grow to about 799.4 M, whereas Average Assets are forecasted to decline to about 1.4 B. Chemed Corp is scheduled to announce its earnings tomorrow. The upcoming quarterly report is expected on the 23rd of February 2023. As some conservatives are trying to avoid health care providers & services space, we'll digest Chemed Corp a little further and explain its current market possibilities. We will evaluate why we are still confident in anticipation of a recovery. Chemed Corp chance of bankruptcy is under 1 percent. Will Chemed Corp shareholders continue to pick up in March?
Published over a month ago
View all stories for Chemed Corp | View All Stories
Macroaxis uses a strict editorial review process to publish our stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.

Reviewed by Vlad Skutelnik

Chemed Corp secures Sharpe Ratio (or Efficiency) of -0.0081, which signifies that the company had -0.0081% of return per unit of standard deviation over the last 3 months. Macroaxis philosophy in foreseeing the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Chemed Corp exposes twenty-one different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Chemed Corp mean deviation of 0.7781, and Risk Adjusted Performance of (0.007272) to double-check the risk estimate we provide.
Typically, a company's financial statements are the reports that show the financial position of the company. There are three main documents that fall into the category of financial statements. These documents include Chemed Corp income statement, its balance sheet, and the statement of cash flows. Potential Chemed Corp investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Chemed Corp investors may use each financial statement separately, they are all related. The changes in Chemed Corp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Chemed Corp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
The goal of Chemed Corp fundamental analysis is to do accurate financial forecasts. There are several possible objectives to fundamental analysis, such as projecting of Chemed Corp performance into the future periods or doing a reasonable stock valuation. The intrinsic value of Chemed Corp shares is the value that is considered the true value of the share. If the intrinsic value of Chemed is higher than its market price, buying is generally recommended. If it is equal to the market price, it is recommended to hold; and if it is less than the market price, then one should sell all shares Chemed Corp.
Please read more on our fundamental analysis page.

Are Chemed Corp Earnings Expected to grow?

The future earnings power of Chemed Corp involves the interaction of many company-specific, industry, and economic forces. Earnings estimates embody investors' opinions of Chemed Corp factors such as sales growth, product demand, competitive industry environment, profit margins, and cost controls. Chemed Corp stock prices adjust as these expectations change or are proven wrong. The main thing to remember is that equities with high expected earnings growth tend to underperform the market because it is usually difficult to meet the market's high expectations. Companies with low earnings expectations tend to do better than expected. Please use our latest analysis of Chemed expected earnings.

And What about dividends?

A dividend is the distribution of a portion of Chemed Corp earnings, decided and managed by the company's board of directors and paid to a class of its shareholders. Note, announcements of dividend payouts are generally accompanied by a proportional increase or decrease in a company's stock price. Chemed Corp dividend payments follow a chronological order of events, and the associated dates are important to determine the shareholders who qualify for receiving the dividend payment. Chemed one year expected dividend income is about USD1.21 per share.
The current year Dividend Yield is expected to grow to 0.003679, whereas Payment of Dividends and Other Cash Distributions is forecasted to decline to (23.8 M).
Last ReportedProjected for 2023
Payment of Dividends and Other Cash Distributions-22 M-23.8 M
Dividend Yield 0.0027  0.003679 
Dividends per Basic Common Share 1.48  1.41 
Investing in dividend-paying stocks, such as Chemed Corp is one of the few strategies that are good for long-term investment. Ex-dividend dates are significant because investors in Chemed Corp must own a stock before its ex-dividend date to receive its next dividend.
This type of analysis is very useful when you want to generate a past dividend schedule and payout information for Chemed Corp. Then that information in the form of graph and calendar can be used to fully explain how Du Pont dividends can provide a real clue to its valuation.

How does Chemed utilize its cash?

To perform a cash flow analysis of Chemed Corp, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Chemed Corp is receiving and how much cash it distributes out in a given period. The Chemed Corp cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Chemed Corp Net Cash Flow from Operations is projected to increase significantly based on the last few years of reporting. The past year's Net Cash Flow from Operations was at 309.89 Million

Chemed Corp Gross Profit

Chemed Corp Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Chemed Corp previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Chemed Corp Gross Profit growth over the last 10 years.
Please check Gross Profit in more details.

What is the case for Chemed Corp Investors

Institutional investors typically avoid acquiring a high percentage of Chemed Corp stocks because performing such an act may violate securities laws. They are usually not investing their own money, but rather making investments on behalf of their clients. Let's take a look at how the ownership of Chemed is distributed among investors.

Ownership Allocation

The market capitalization of Chemed Corp is $7.61 Billion. The majority of Chemed Corp outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Chemed Corp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Chemed Corp. Please pay attention to any change in the institutional holdings of Chemed Corp as this could imply that something significant has changed or about to change at the company. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.


Institutions
95.79%
Retail Investors1.35
Insiders2.86
Institutions95.79

Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Chemed Corp has an asset utilization ratio of 159.32 percent. This indicates that the company is making $1.59 for each dollar of assets. An increasing asset utilization means that Chemed Corp is more efficient with each dollar of assets it utilizes for everyday operations.


Assets Non Current
1.2 B		Goodwill
752.7 M
Current Assets255.4 Million11.74
Assets Non Current1.15 Billion53.0
Goodwill752.67 Million34.6
Tax Assets14.44 Million0.66

Chemed may start a relapse in March

The kurtosis is down to 0.38 as of today. Chemed Corp exhibits very low volatility with skewness of -0.14 and kurtosis of 0.38. However, we advise investors to further study Chemed Corp technical indicators to ensure that all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Chemed Corp's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Chemed Corp's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Our Conclusion on Chemed Corp

Although some firms within the medical care facilities industry are still a little expensive, even after the recent corrections, Chemed Corp may offer a potential longer-term growth to shareholders. With a somewhat neutral outlook on your 90 days horizon, it may be better to hold off any trading activity and neither buy new shares of Chemed nor exit your existing holdings in the Stock. It seems the expected volatility has not yet been fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Chemed Corp.

Editorial Staff

Ellen Johnson is a Member of Macroaxis Editorial Board. Ellen covers public companies in North America, focusing primarily on valuation and volatility. Six years of experience in predictive investment analytics and risk management. View Profile
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Chemed Corp. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2023 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY